1. Home
  2. STHO vs CATX Comparison

STHO vs CATX Comparison

Compare STHO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STHO

Star Holdings Shares of Beneficial Interest

SELL

Current Price

$7.61

Market Cap

120.0M

Sector

Real Estate

ML Signal

SELL

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

N/A

Current Price

$0.84

Market Cap

113.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STHO
CATX
Founded
2022
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.0M
113.9M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
STHO
CATX
Price
$7.61
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $9.43
AVG Volume (30 Days)
39.3K
★ 4.3M
Earning Date
11-06-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.73
N/A
EPS
N/A
★ N/A
Revenue
★ $110,143,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$91.56
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.25
$0.78
52 Week High
$9.94
$6.16

Technical Indicators

Market Signals
Indicator
STHO
CATX
Relative Strength Index (RSI) 37.25 26.31
Support Level $7.36 $0.78
Resistance Level $9.10 $2.40
Average True Range (ATR) 0.29 0.11
MACD 0.05 0.04
Stochastic Oscillator 12.94 9.99

Price Performance

Historical Comparison
STHO
CATX

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: